Clinical trial · Observational
Development and Management of Registry in Patients With Gynecologic Cancer in Korea
NCT05912972CI-TRIAL-00067371recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this observational study is to identify and analyze the characteristics, treatment trends, prognostic factors and survival prognosis of Korean gynecologic cancer patients. Ultimately, the final goal is to contribute to the development of safe surgical methods and treatment for gynecologic cancer to improve survival rates.
Conditions
Conditions (5)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cervical Cancer | Malignant Cervical Neoplasm | CURATED_EXACT | 0.92 |
| Endometrial Cancer | Malignant Endometrial Neoplasm | CURATED_BROADER | 0.80 |
| Fallopian Tube Cancer | Malignant Fallopian Tube Neoplasm | ALIAS | 0.90 |
| Ovarian Cancer | Malignant Ovarian Neoplasm | CURATED_EXACT | 0.92 |
| Peritoneal Cancer | Malignant Peritoneal Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Patient registry | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- label
- Cervical cancer
- description
- No interventions
- interventionNames
- Other: Patient registry
- label
- Endometrial cancer
- description
- No interventions
- interventionNames
- Other: Patient registry
- label
- Ovarian cancer, Fallopian tube cancer, Peritoneal cancer
- description
- No interventions
- interventionNames
- Other: Patient registry
Primary outcomes (1)
- measure
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Female patients 18 years or older * Written informed consent (prospective cohort) * Confirmed diagnosis of cervical cancer, endometrial cancer or ovarian cancer Exclusion Criteria: * Unconfirmed diagnosis of cervical cancer, endometrial cancer or ovarian cancer
References
Publications (0)
Data not yet available
No reference posted for this study.